SENTINEL CH. SpA

SENTINEL CH. SpA — FDA 510(k) Submissions

SENTINEL CH. SpA has submitted 12 FDA 510(k) premarket notifications since 2007, of which 12 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Cardiac C-reactive Protein, Antigen, Antiserum, And Control, C-reactive Protein, Antigen, Antiserum, And Control, Bromcresol Purple Dye-binding, Albumin, Lipoprotein, Low-density, Antigen, Antiserum, Control, Assay, Porphyrin, Spectrophotometry, Lithium . Use the specialty filter in the sidebar to narrow results.